Citadel Advisors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,500
Closed -$176K 14737
2022
Q1
$176K Sell
10,500
-4,000
-28% -$69.9K ﹤0.01% 11676
2021
Q4
$290K Sell
14,500
-1,900
-12% -$35.8K ﹤0.01% 11008
2021
Q3
$298K Sell
16,400
-3,200
-16% -$73.4K ﹤0.01% 11080
2021
Q2
$529K Buy
19,600
+4,500
+30% +$126K ﹤0.01% 9941
2021
Q1
$453K Sell
15,100
-49,400
-77% -$1.68M ﹤0.01% 9890
2020
Q4
$1.85M Sell
64,500
-18,300
-22% -$494K ﹤0.01% 5496
2020
Q3
$2.02M Buy
82,800
+1,800
+2% +$38.8K ﹤0.01% 4691
2020
Q2
$1.45M Buy
81,000
+57,600
+246% +$757K ﹤0.01% 5141
2020
Q1
$190K Buy
23,400
+4,400
+23% +$50.3K ﹤0.01% 8061
2019
Q4
$251K Sell
19,000
-83,500
-81% -$1.01M ﹤0.01% 7859
2019
Q3
$1.22M Buy
102,500
+84,000
+454% +$1.55M ﹤0.01% 5250
2019
Q2
$453K Buy
+18,500
New +$533K ﹤0.01% 6975

Other funds holding CVET

Citadel Advisors's CVET Position: Q4 2022 in Review

Citadel Advisors sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 2,455,847 shares — an estimated $51.3M sold.

Citadel Advisors first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $51.3M in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Citadel Advisors reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 2,455,847 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $51.3M.
  • Citadel Advisors first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Citadel Advisors's Covetrus, Inc. Common Stock position peaked at $51.3M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.